Core Insights - The company Kefu Medical (301087) reported a significant increase in revenue and net profit for the third quarter of 2025, indicating strong financial performance [1][2] Financial Performance - The company achieved a revenue of 902,027,920.61 yuan for the third quarter, a year-on-year increase of 30.72% [1] - Cumulative revenue from the beginning of the year to the reporting period reached 2,397,791,920.73 yuan, reflecting a growth of 6.63% [1] - Net profit attributable to shareholders for the third quarter was 92,829,784.04 yuan, up 38.68% year-on-year [1] - Year-to-date net profit attributable to shareholders was 260,217,303.07 yuan, showing a growth of 3.30% [1] - The net profit after deducting non-recurring gains and losses for the third quarter was 85,802,669.67 yuan, a 62.68% increase year-on-year [1] - Year-to-date net profit after deducting non-recurring gains and losses was 221,991,674.51 yuan, with a growth of 1.46% [1] Earnings and Cash Flow - The net cash flow from operating activities for the year-to-date period was 589,991,388.19 yuan, an increase of 35.36% [2] - Basic earnings per share for the third quarter were 0.46 yuan, up 39.39% year-on-year [2] - Year-to-date basic earnings per share were 1.28 yuan, reflecting a growth of 3.23% [2] - Diluted earnings per share for the third quarter were also 0.46 yuan, with a year-on-year increase of 39.39% [2] - Year-to-date diluted earnings per share were 1.27 yuan, showing a growth of 3.25% [2] Asset and Equity Position - Total assets at the end of the reporting period amounted to 6,540,292,345.50 yuan, a growth of 1.83% compared to the end of the previous year [2] - Equity attributable to shareholders at the end of the reporting period was 4,713,657,384.44 yuan, a decrease of 1.73% compared to the end of the previous year [2] - The total number of common shareholders at the end of the reporting period was 17,174 [2]
可孚医疗（301087）披露2025年第三季度报告，10月30日股价上涨4.94%